The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single award indefinite delivery contract to Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, with a potential value of $866,632.41 to provide radio pharmaceuticals. Under this contract, two firm fixed price delivery orders have been awarded to date for a total of $441,612.06 to supply radiopharmaceutical products through January 2023...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for radiopharmaceuticals. The contract has a potential value of $638,068.78 and period of performance through April 30, 2025. Associated delivery orders include a $212,636.63 firm fixed-price order for radiopharmaceuticals with performance in Orlovista,...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, an Indefinite Delivery Contract (IDC) valued up to $3.5 million for the provision of radioactive isotopes and related radiopharmaceutical products and services. This single-award IDC with the VA VISN 10 network has a period of performance through September 30, 2026. Under this IDC, Jubilant Radiopharma, a...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, with a potential value of $420,000. The contract establishes Jubilant Radiopharma as the supplier of nuclear medicine radiopharmaceuticals to support VA healthcare programs in the Norcross, Georgia area over a five-year period of performance from December...
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA-VHA) awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc. doing business as Jubilant Radiopharma for the provision of radiopharmaceutical supplies. Under the single award agreement, which has a potential value of $1,379,724.67 and expires on March 31, 2028, the contractor may receive delivery orders for radiopharmaceuticals through April 30, 2024. The first...